Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.
about
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Lenalidomide/melphalan/dexamet ...... tudy with long-term follow up.
@en
type
label
Lenalidomide/melphalan/dexamet ...... tudy with long-term follow up.
@en
prefLabel
Lenalidomide/melphalan/dexamet ...... tudy with long-term follow up.
@en
P2093
P2860
P50
P1433
P1476
Lenalidomide/melphalan/dexamet ...... tudy with long-term follow up.
@en
P2093
Anja Freiberger
Anna Jauch
Arnt V Kristen
Axel Benner
Christoph Kimmich
Ernst Hund
Jörg Beimler
Marianne Gawlik
Markus Zorn
P2860
P304
P356
10.3324/HAEMATOL.2016.163246
P577
2017-05-18T00:00:00Z